Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 23:7:13-21.
doi: 10.1016/j.jdin.2021.12.010. eCollection 2022 Jun.

Survival outcomes and epidemiology of Merkel cell carcinoma of the lower limb and hip: A Surveillance, Epidemiology, and End Results analysis 2000-2018

Matteo Scampa  1 , Rastine Merat  2 , Evangelia Tzika  2 , Daniel F Kalbermatten  1 , Carlo M Oranges  1
Affiliations

Survival outcomes and epidemiology of Merkel cell carcinoma of the lower limb and hip: A Surveillance, Epidemiology, and End Results analysis 2000-2018

Matteo Scampa et al. JAAD Int. .

Abstract

Background: Merkel cell carcinoma of lower limb and hip skin is a rare skin tumor that has a high recurrence rate.

Objective: To assess epidemiology and survival outcomes of the lower limb and hip Merkel cell carcinoma, which are less addressed in the literature.

Methods: The Surveillance, Epidemiology, and End Results database was searched for all cases of skin Merkel cell carcinoma between 2000 and 2018. Demographic and clinicopathologic features were compared between lower limb and other skin localizations using the t test or χ2 test. The overall survival (OS) of lower limb Merkel cell carcinoma was calculated using the Kaplan-Meier method. Subgroups were compared using the log rank test. Multivariate cox regression was used to identify independent prognostic factors.

Results: In total, 976 patients were identified. The mean age was 72.7 years. The median OS was 68 months, better than that of other localizations. Older age, regional lymph node, and distant metastasis were associated with low OS. Surgery with >1-cm margins, when associated with radiotherapy, had the best OS. Age, tumor size, lymph node status, presence of metastasis, and treatment sequence were identified as independent prognostic factors.

Conclusion: Lower limb and hip Merkel cell carcinomas have better OS than tumors in other skin localizations. In this dataset, the best OS was ensured using surgery with >1-cm margins and adjuvant radiotherapy.

Keywords: MCC, Merkel cell carcinoma; MCPyV, Merkel cell polyomavirus; Merkel; OS, overall survival; SEER; SEER, Surveillance, Epidemiology, and End Results; SOC, standard of care; carcinoma; population; survival; treatment.

PubMed Disclaimer

Conflict of interest statement

None disclosed.

Figures

Fig 1
Fig 1
Age and registry distribution.
Fig 2
Fig 2
Localization, age, and treatment survival curves.
Fig 3
Fig 3
Staging survival curves.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Paulson K.G., Park S.Y., Vandeven N.A., et al. Merkel cell carcinoma: current US incidence and projected increases based on changing demographics. J Am Acad Dermatol. 2018;78(3):457–463. doi: 10.1016/j.jaad.2017.10.028. - DOI - PMC - PubMed
    1. Garbutcheon-Singh K.B., Curchin D.J., McCormack C.J., Smith S.D. Trends in the incidence of Merkel cell carcinoma in Victoria, Australia, between 1986 and 2016. Australas J Dermatol. 2020;61(1):e34–e38. doi: 10.1111/ajd.13131. - DOI - PubMed
    1. Kaae J., Hansen A.V., Biggar R.J., et al. Merkel cell carcinoma: incidence, mortality, and risk of other cancers. J Natl Cancer Inst. 2010;102(11):793–801. doi: 10.1093/jnci/djq120. - DOI - PubMed
    1. Agelli M., Clegg L.X. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol. 2003;49(5):832–841. doi: 10.1016/S0190-9622(03)02108-X. - DOI - PubMed
    1. Freeman M.B., Holman D.M., Qin J., Lunsford N.B. Merkel cell carcinoma incidence, trends, and survival rates among adults aged ≥50 years from United States Cancer Statistics. J Am Acad Dermatol. 2019;80(4):1154–1156. doi: 10.1016/j.jaad.2018.10.045. - DOI - PMC - PubMed

LinkOut - more resources